HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Few FH mutations in sporadic counterparts of tumor types observed in hereditary leiomyomatosis and renal cell cancer families.

Abstract
Loss of function mutations in the fumarate hydratase (fumarase, FH) gene were recently identified as the cause for dominantly inherited uterine and cutaneous leiomyomas and renal cell cancer. To further evaluate the role of FH in tumorigenesis, we screened FH mutations from tumor types seen in hereditary leiomyomatosis and renal cell cancer mutation carriers-41 uterine and 10 cutaneous leiomyomas, 52 renal cell carcinomas, 53 sarcomas, 29 prostate carcinomas, and 15 lobular breast carcinomas. Few mutations were detected. Biallelic inactivation of FH was found in one uterine leiomyosarcoma, one cutaneous leiomyoma, and one soft tissue sarcoma. Whereas the two former lesions were shown to originate from a germ-line mutation, the soft tissue sarcoma is to our knowledge the first example of purely somatic inactivation of FH in tumors.
AuthorsMaija Kiuru, Rainer Lehtonen, Johanna Arola, Reijo Salovaara, Heikki Järvinen, Kristiina Aittomäki, Jari Sjöberg, Tapio Visakorpi, Sakari Knuutila, Jorma Isola, Brett Delahunt, Riitta Herva, Virpi Launonen, Auli Karhu, Lauri A Aaltonen
JournalCancer research (Cancer Res) Vol. 62 Issue 16 Pg. 4554-7 (Aug 15 2002) ISSN: 0008-5472 [Print] United States
PMID12183404 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Fumarate Hydratase
Topics
  • Base Sequence
  • Carcinoma, Renal Cell (enzymology, genetics)
  • Female
  • Fumarate Hydratase (genetics)
  • Germ-Line Mutation
  • Humans
  • Kidney Neoplasms (enzymology, genetics)
  • Leiomyoma (enzymology, genetics)
  • Leiomyosarcoma (enzymology, genetics)
  • Male
  • Molecular Sequence Data
  • Mutation, Missense
  • Prostatic Neoplasms (enzymology, genetics)
  • Skin Neoplasms (enzymology, genetics)
  • Uterine Neoplasms (enzymology, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: